Matt Kazan, M.P.P., provides strategic advice to Avalere’s health plan and life sciences clients navigating the complex legislative and regulatory policy environment, with a particular expertise in Medicare Part D and Medicare Advantage (MA). Prior to joining Avalere, he spent over a decade on the U.S. Senate Committee on Finance health staff under Senators Max Baucus and Ron Wyden. As senior health policy adviser, Kazan was the primary policy adviser on policy issues, including MA, Medicare Part D and all drug reimbursement under Medicare, chronic disease, dual-eligibles, postacute care, the Medicare Shared Savings Program, and Medicare and Medicaid program integrity. During his tenure, he was involved in a variety of major legislative efforts including the Affordable Care Act, the Bipartisan Budget Act of 2018, the Medicare Access and CHIP Reauthorization Act of 2015, the Children’s Health Insurance Program Reauthorization Act of 2009, and the American Recovery and Reinvestment Act. Mr. Kazan holds an undergraduate degree from the University of Denver and an M.P.P. from the George Washington University.
Principal, Avalere Health LLC